Status:
COMPLETED
Serum Procalcitonin
Lead Sponsor:
Mayo Clinic
Conditions:
Subarachnoid Hemorrhage (SAH)
Eligibility:
All Genders
18+ years
Brief Summary
Systemic inflammatory response syndrome (SIRS) is characterized by changes in body temperature, heart rate, respiratory rate, or peripheral blood white cell count, and is often a heralding manifestati...
Detailed Description
Hypothesis: We hypothesize that PCT can be used to define normal (SIRS without infection) and abnormal values SIRS with infection (i.e., blood, lung, urinary, spinal fluid) in a population of patients...
Eligibility Criteria
Inclusion
- All adult patients admitted for an expected ICU stay of more than 24 hrs over a 6-month period
Exclusion
- Patients with known hyper-bilirubinemia (\>0.4 mg/ml) or hypertriglyceridemia (\>10 g/l) will be excluded since this can interfere with measurements of PCT
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00954551
Start Date
July 1 2009
End Date
March 1 2011
Last Update
June 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224